|Also listed as: Immunoglobulin deficiency syndromes||Integrative Therapy Quick Links:|
- This information has been edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).
- Immune Deficiency Foundation. .
- Michigan Immunodeficiency Foundation. .
- National Institute of Allergy and Infectious Diseases. .
- National Organization for Rare Disorders. .
- National Primary Immunodeficiency Resource Center. .
- Natural Standard: The Authority on Integrative Medicine. . Copyright © 2010.
- University of Virginia Health System. .
- Good scientific evidence:
- Ginseng: Several studies suggest that ginseng can effectively enhance immune system function.
- Avoid ginseng if known allergy to plants in the Araliaceae family. There has been a report of a serious life-threatening skin reactions, possibly caused by contaminants in the ginseng formulation.
- Zinc: Zinc appears to be an essential trace element for the immune system, but research on the effect of zinc supplementation on immune function is scant and mostly focused on patients with specific diseases. Zinc gluconate appears to exert beneficial effects on immune cells, improving CD3 and CD4 counts (white blood cells that help coordinate the immune response) and increasing CD4/CD8 ratios in children. There are relatively few studies that examine zinc levels and the effects of zinc supplementation on the health of the elderly population. Further research is needed before a firm conclusion can be made.
- Zinc is generally considered safe when taken at the recommended dosages. Avoid zinc chloride since studies have not been done on its safety or effectiveness. While zinc appears safe during pregnancy in amounts lower than the established upper intake level, caution should be used since studies cannot rule out the possibility of harm to the fetus.
- Unclear or conflicting scientific evidence:
- Arginine (L-arginine): Preliminary research results suggest that arginine supplementation may enhance the immune response elicited by the pneumococcal vaccine in older people. More studies are needed to confirm these results.
- Avoid if allergic to arginine. Avoid with history of stroke, liver disease, or kidney disease. Avoid if pregnant or breastfeeding. Use cautiously if taking blood-thinning drugs (like warfarin), blood pressure drugs, or herbs or supplements with similar effects. Check blood potassium levels.
- Astragalus: Astragalus has been suggested as an immune system stimulant in preliminary laboratory and animal research, and in traditional accounts. Reliable human studies are lacking. High quality human research is necessary before a firm conclusion can be drawn.
- Avoid if allergic to astragalus, peas, or any related plants or with a history of Quillaja bark-induced asthma. Avoid with aspirin or aspirin products or herbs or supplements with similar effects. Avoid with inflammation (swelling) or fever, stroke, transplant, or autoimmune diseases (like HIV/AIDS). Stop use two weeks before surgery/dental/diagnostic procedures with a risk of bleeding and avoid use immediately after these procedures. Use cautiously with bleeding disorders, diabetes, high blood pressure, lipid disorders, or kidney disorders. Use cautiously with blood-thinners, blood sugar drugs, diuretics, or herbs and supplements with similar effects. Avoid if pregnant or breastfeeding.
- Beta-carotene: Preliminary research of beta-carotene for immune system maintenance or stimulation shows mixed results. Further research is needed before a conclusion can be drawn.
- Avoid if sensitive to beta-carotene, vitamin A, or any other ingredients in beta-carotene products.
- Cat's claw: A few early studies suggest that cat's claw may boost the immune system. However, results from different studies have not agreed with each other. Therefore, further research is necessary in order to determine whether cat's claw can effectively enhance the immune response.
- Avoid if allergic to Cat's claw, Uncaria plants, or plants in the Rubiaceae family, such as gardenia, coffee, or quinine. Avoid with a history of conditions affecting the immune system (such as AIDS, HIV, some types of cancer, multiple sclerosis, tuberculosis, rheumatoid arthritis, lupus). Use cautiously with bleeding disorders, history of stroke, or if taking drugs that may increase the risk of bleeding. Stop use two weeks before surgery/dental/diagnostic procedures with bleeding risk, and do not use immediately after these procedures. Avoid if pregnant or breastfeeding. Cat's claw may be contaminated with other Uncaria species. Reports exist of the potentially toxic Texan grown plant Acacia gregii being substituted for cat's claw.
- Copper: Copper is involved in the development of immune cells and immune function in the body. Severe copper deficiency appears to have adverse effects on immune function, although the exact mechanism is not clear.
- Avoid if allergic or hypersensitive to copper. Avoid use of copper supplements during the early phase of recovery from diarrhea. Avoid with hypercupremia, occasionally observed in disease states including cutaneous leishmaniasis, sickle-cell disease, unipolar depression, breast cancer, epilepsy, measles, Down syndrome, and controlled fibrocalculous pancreatic diabetes (a unique form of secondary diabetes mellitus). Avoid with genetic disorders affecting copper metabolism such as Wilson's disease, Indian childhood cirrhosis, or idiopathic copper toxicosis. Avoid with HIV/AIDS. Use cautiously with water containing copper concentrations greater than 6 milligrams/liter. Use cautiously with anemia, arthralgia, and muscle pain. Use cautiously if taking oral contraceptives. Use cautiously if at risk for selenium deficiency. The recommended dietary allowance (RDA) is 1,000 micrograms for pregnant women. The RDA is 1300 micrograms for breastfeeding women.
- Echinacea: Echinacea has been studied alone and in combination preparations for immune system stimulation (including in patients receiving cancer chemotherapy). It remains unclear if there are clinically significant benefits. Additional studies are needed in this area before conclusions can be drawn regarding safety or effectiveness.
- Avoid if allergic to plants in the Asteraceaeor Compositaefamily (ragweed, chrysanthemums, marigolds, daisies). Avoid Echinacea injections. Avoid if history of liver disease or if taking amoxicillin. Avoid in organ transplant recipients. Use cautiously if driving or operating heavy machinery or if history of asthma, diabetes, conditions affecting the immune systems (like lupus, TB, AIDS-HIV), and rheumatologic conditions (rheumatoid arthritis). Avoid if pregnant or breastfeeding. Tinctures may contain large amounts of alcohol.
- Gamma linolenic acid (GLA): Few clinical trials have investigated the effect of GLA on immune responses in healthy human subjects. Results from one randomized clinical trial suggest that GLA, as blackcurrant seed oil, may offer some benefits. Further, well-designed clinical trials are required before definite conclusions can be made.
- Use cautiously with agents that increase the risk of bleeding like anticoagulants and anti-platelet drugs. Avoid if pregnant or breastfeeding.
- Goldenseal: Goldenseal is sometimes suggested to be an immune system stimulant. However, there is little human or laboratory evidence in this area. More research is needed before a firm conclusion can be drawn.
- Avoid if allergic or hypersensitive to goldenseal or any of its constituents, like berberine and hydrastine. Use cautiously with bleeding disorders, diabetes, or low blood sugar. Avoid if pregnant or breastfeeding.
- Maitake mushroom: Animal and laboratory studies suggest that beta-glucan extracts from maitake may alter the immune system. However, maitake has not been studied thoroughly in humans and its effects are not well known. Because it has been used historically as a food, it is thought that low doses may be safe. Avoid if allergic or hypersensitive to Grifola frondosa (maitake). Use caution with a history of low blood pressure, diabetes, or with drugs, herbs, or supplements that treat such conditions. Avoid if pregnant or breastfeeding.
- Massage: Preliminary evidence suggests that massage therapy may preserve immune function. Further research is needed before a firm conclusion can be made.
- Avoid with bleeding disorders, low platelet counts, or if taking blood-thinning medications (such as heparin or warfarin). Areas should not be massaged where there are fractures, weakened bones from osteoporosis or cancer, open/healing skin wounds, skin infections, recent surgery, or blood clots. Use cautiously if history of physical abuse or if pregnant or breastfeeding. Massage should not be used as a substitute for more proven therapies for medical conditions. Massage should not cause pain to the client.
- Meditation: Preliminary research reports increased antibody response after meditation. Further study is needed to confirm these findings.
- Use cautiously with underlying mental illnesses. People with psychiatric disorders should consult with their primary mental healthcare professional(s) before starting a program of meditation, and should explore how meditation may or may not fit in with their current treatment plan. Avoid with risk of seizures. The practice of meditation should not delay the time to diagnosis or treatment with more proven techniques or therapies, and should not be used as the sole approach to illnesses.
- Mistletoe: A few small trials found mistletoe to be promising as an immunostimulant in individuals with the common cold. Further research is needed to confirm these results.
- Avoid if allergic or hypersensitive to mistletoe or to any of its constituents. Anaphylactic reactions (life threatening) have been described after injections of mistletoe. Avoid with acute highly febrile inflammatory disease, thyroid disorders, seizure disorders, or heart disease. Use cautiously with diabetes, glaucoma, or with cholinergics.
- Probiotics: Lactobacillus in fermented milk, low-fat milk, or lactose-hydrolyzed low-fat milk may enhance immune function. Bifidobacterium may as well, including in the elderly. However, commercially produced yogurt may not yield similar benefits. There is some evidence that probiotics added during food preparation (e.g. waffles with Enterococcus faecium M-74 added) may enhance immune functioning. More studies are needed, particularly with yogurt, before a firm conclusion can be made.
- Probiotics are generally considered safe and well-tolerated. Avoid if allergic or hypersensitive to probiotics. Use cautiously if lactose intolerant.
- Vitamin A (retinol): Vitamin A deficiency may compromise immunity, but there is no clear evidence that additional vitamin A supplementation is beneficial for immune function in patients who are not vitamin A deficient.
- Avoid if allergic or hypersensitive to vitamin A. Vitamin A toxicity can occur if taken at high dosages. Use cautiously with liver disease or alcoholism. Smokers who consume alcohol and beta-carotene may be at an increased risk for lung cancer or heart disease. Vitamin A appears safe in pregnant women if taken at recommended doses. Use cautiously if breastfeeding because the benefits or dangers to nursing infants are not clearly established.
- Vitamin B6 (pyridoxine): Vitamin B6 is important for immune system function in older individuals. One study found that the amount of vitamin B6 required to reverse immune system impairments in elderly people was more than the current recommended dietary allowance (RDA). Well-designed clinical trials on vitamin B6 supplementation for this indication are needed before a recommendation can be made.
- Some individuals seem to be particularly sensitive to vitamin B6 and may have problems at certain doses. Avoid excessive dosing. Vitamin B6 is likely safe when used orally in doses not exceeding the RDA. The RDA for pregnant women is 1.9 milligrams per day. There is some concern that high-dose pyridoxine taken by a pregnant mother can cause seizures in a newborn. The RDA in breastfeeding women is 2 milligrams per day.
- Vitamin E: Studies of the effects of vitamin E supplementation on immune system function have yielded mixed results. Further research is needed before a clear conclusion can be drawn.
- Avoid if allergic or hypersensitive to vitamin E. For short periods of time, vitamin E supplementation is generally considered safe at doses up to 1,000 milligrams per day. Avoid doses higher than 1,000 milligrams a day. Avoid with retinitis pigmentosa (loss of peripheral vision). Use cautiously with bleeding disorders. The recommended dose of vitamin E for pregnant women of any age is 15 milligrams, and for breastfeeding women of any age is 19 milligrams. Use beyond this level in pregnant women is not recommended.
- Fair negative scientific evidence:
- DHEA (dehydroepiandrosterone): DHEA (dehydroepiandrosterone) is a naturally occurring hormone that is produced by the adrenal glands. Some textbooks and review articles have suggested that DHEA can stimulate the immune system. However, current scientific evidence does not support this claim.
- Avoid if allergic to DHEA. Avoid with a history of seizures. Use cautiously with adrenal or thyroid disorders or if taking anticoagulants or drugs, herbs, or supplements for diabetes, heart disease, seizure, or stroke. Stop use two weeks before surgery/dental/diagnostic procedures with bleeding risk, and do not use immediately after these procedures. Avoid if pregnant or breastfeeding.
- Lycopene: It has been proposed that lycopene and other carotenoids, such as beta-carotene, may stimulate the immune system. However, several studies of lycopene supplements and tomato juice intake in humans report no effects on the immune system.
- Avoid if allergic to tomatoes or to lycopene. Due to a lack of conclusive data, avoid if pregnant or breastfeeding.
- Currently, there is no known method of prevention for antibody deficiencies that are inherited.
- The pneumococcal vaccine and pneumococcal 7-valent conjugate vaccine may be beneficial for patients who have antibody deficiencies. Patients should consult their healthcare providers to determine whether vaccinations are recommended.
- Avoiding close contact with individuals who have contagious illnesses may help reduce the risk of acquiring infections.
- Practicing good hygiene and regularly washing the hands with soap and water may help reduce the risk of acquiring infections.
Types of the disease
- Common Variable Immunodeficiency (CVID):
- Overview: Common variable immunodeficiency (CVID), also called hypogammaglobulinemia or adult onset hypogammaglobulinemia, is a relatively common primary immune deficiency. Primary immune deficiencies are disorders that occur because part of the body's immune system does not function properly. These disorders are caused by intrinsic or genetic defects in the immune system. Therefore, individuals who have primary immune deficiencies are born with the disorder.
- The disorder is characterized by a lack of antibody producing B-cells or plasma cells, low levels of most or all types of immunoglobulin, and recurrent bacterial infections.
- While the exact incidence of CVID is unknown, researchers estimate that about one out of 50,000 individuals develop the disorder.
- Although decreased serum levels of immunoglobulin G (IgG) and immunoglobulin A (IgA) are characteristic of the disorder, about 50% of CVID patients also have decreased immunoglobulin M (IgM) levels. In addition, about half of CVID patients experience some T-lymphocyte dysfunction.
- No clear pattern of inheritance has been observed. In most cases, there is no family history of immunodeficiency. However, when more than one family member is diagnosed with CVID, researchers believe it is the result of autosomal recessive inheritance.
- Initially, the disorder was called acquired agammaglobulinemia. This name generally applied to patients who developed the immunodeficiency when they were 20-50 years old. However, today the use of the term is discouraged in order to avoid confusion with the acquired immune deficiency syndrome (AIDS). Instead, CVID that develops later in life is now referred to as adult-onset hypogammaglobulinemia.
- In general, the expected survival rate for male and female patients is 92% and 94%, respectively. Factors associated with fatality include low levels of IgG, poor T-cell responses to antigens, and a low percentage of B cells. Deaths related to CVID are usually the result of lymphoma. Other potential causes of death include right-sided heart failure secondary to chronic lung infection, liver failure, and malnutrition (resulting from gastrointestinal tract disease).
The first signs of the deficiency are recurrent bacterial infections, which may occur as early as infancy or as late as the fourth decade of life. Common symptoms include recurrent infections of the ears, bronchi, sinuses, and lungs. Bronchiectasis (widening and scarring of the bronchial tubes) infections of the bronchi are severe. Patients with bronchiectasis may have a regular morning cough that produces yellow or green sputum. Many CVID patients have an enlarged spleen and lymph nodes. Other patients may develop painful inflammation of the knees, ankle, elbows, or wrist joints. Gastrointestinal symptoms may include abdominal pain, bloating, nausea, vomiting, diarrhea, or weight loss. Some patients develop autoantibodies, which are antibodies that mistakenly attack the body's tissues. Autoantibodies can destroy one or more types of body tissues, cause abnormal organ growth, or impair organ function. Autoantibodies commonly affect blood components (like red blood cells, connective tissues, and blood vessels), endocrine glands (like the thyroid or pancreas), as well as muscles, joints, and the skin.
- Diagnosis: A nephelometry blood test may be performed to diagnose CVID. The disorder is diagnosed after significantly decreased IgG and IgA levels are observed in the patient's blood. Some patients may also have decreased IgM levels. During the procedure, a sample of blood is taken from the patient. Anti-immunoglobulins are added to the blood sample. A medical instrument then measures the movement of particles in a substance that is caused by the interaction between immunoglobulins and anti-immunoglobulins. The test quickly and accurately measures the amount of IgM, IgG, and IgA in the patient's blood. Healthy individuals have 100-400 milligrams of IgA per deciliter of blood, 560-1,800 milligrams of IgG per deciliter of blood, and 45-250 milligrams of IgM per deciliter blood.
- Treatment: While there is currently no cure for CVID, various treatments may help relieve symptoms and resolve infections associated with the disease. Intravenous immune globulin (IVIG) therapy is used most often to treat CVID patients.
- Immune globulin may be administered intravenously (injected into the vein) or subcutaneously (injected below the skin). Solutions of 3-12% intravenous immunoglobulin (IVIG) have been used on a regular basis to maintain a trough level of 400-500 milligrams/deciliter in adults. A dose of 400-600 milligrams/deciliter every two to four weeks is usually required. In patients with structural lung damage, a trough level of 700-800 milligrams/deciliter is generally required.
- The most common side effects of IVIG include backache, nausea, vomiting, chills, low-grade fever, myalgias (general feeling of discomfort), and fatigue. Adverse effects usually occur within 30 minutes of the infusion and typically last for several hours. Slowing the rate of infusion or interrupting the infusion for a few minutes can help prevent side effects. Adverse effects can be treated with antipyretics, diphenhydramine, or corticosteroids. Although anaphylactic reactions to immunoglobulin concentrates are rare, patients who have IgA deficiency have an increased risk for these effects. Long-term intravenous access is not recommended because it can increase the risk of infection.
- Patients with chronic sinusitis or lung disease may need long term treatment with broad spectrum antibiotics such as ampicillin (Principen®), tetracycline (Helidac Therapy®, Sumycin®, or Sumycin® Syrup), cephalexin (Biocef®, Keflex®, Keftab®, Panixine®, or Zartan®), trimethoprim/sulfmethoxazole (Bactrim® or Septra®), or ciprofloxacin (Cipro®).
- Hyperimmunoglobulin E Syndrome (HIES):
- Overview: Hyperimmunoglobulin E syndrome (HIES), also called Job syndrome, is an inherited immunodeficiency that is characterized by recurrent bacterial infections, skin abscesses, and high levels of immunoglobulin E (IgE). Immunoglobulin (Ig) is an antibody that is secreted by immune system cells to detect antigens (foreign substances like bacteria and viruses that enter the body). Once the antibodies attach to the antigen, white blood cells destroy the antigen.
- Even though HIES patients have high levels of IgE in their blood, they are vulnerable to infection and disease because other important immune cells do not function properly. HIES patients are born with abnormal T-cells (type of white blood cells) that are unable to produce enough interferon-gamma, which stimulates white blood cells called macrophages to engulf foreign invaders. Consequently, the immune system's response to antigens is delayed.
- Studies suggest that HIES is a genetic disorder that can be inherited as either an autosomal dominant (AD-HIES) or autosomal recessive (AR-HIES) trait. However, the specific gene involved remains unidentified.
- HIES is an extremely rare disease, with only 250 cases ever reported internationally. Most individuals are not diagnosed until childhood, or sometimes adulthood.
- The oldest reported HIES patient was 60 years old. Most patients die by age 20-30 from severe pulmonary (lung) infections and diseases like aspergillosis.
- Symptoms: Common symptoms of HIES include persistent skin abscesses and infections, recurrent pus in the sinuses, eczema (type of skin rash), itchy skin, and painless skin abscesses (infections). Patients often suffer from recurrent infections such as fungal infections of the mouth and nails, bronchitis, pneumonia, ear infections, sinus infections, bone infections, and gingivitis (gum disease). Some patients may also suffer from skeletal and dental abnormalities such as scoliosis (curved spine), fractured bones (that often go unrecognized because they cause little or no pain), bone and teeth defects, and late shedding and fractures of baby teeth.
- Diagnosis: HIES can be diagnosed after elevated levels of IgE are observed in the blood of patients who suffer from the characteristic symptoms. An enzyme-linked immunosorbent assay (ELISA) test is used to measure the level of antibodies in the blood. Patients are diagnosed with HIES if they have an IgE level greater than two standard deviations higher than normal, and they suffer from characteristic symptoms.
- Treatment: There is currently no cure for HIES. Treatment focuses on resolving the infections commonly associated with the disorder. Antibacterial agents like nafcillin (Nafcil®, Unipen® or Nallpen®), oxacillin (Bactocill® or Prostaphlin®), and ampicillin (Marcillin®, Omnipen®, Polycillin®, Principen®, or Totacillin®) have been used to treat bacterial infections. Antifungals like fluconazole (Diflucan®) and Ketoconazole (Nizoral®) have been used to treat fungal infections. Intravenous immunoglobulin therapy (IVIG) may help to build up the immune system temporarily when patients have severe infections. Intravenous immunoglobulin (IVIG) is made of antibodies extracted from pooled blood donations from hundreds to thousands of donors. The immunoglobulin is typically injected into the patient's vein for about two to four hours a day for two to seven days. The patient usually receives another single dose every 10-21 days or every three to four weeks, depending on the severity of the condition.
- IgG subclass deficiencies:
- Overview: Selective immunoglobulin G (IgG) subclass deficiencies are a group of inherited disorders that occur when subclasses of IgG are not produced. There are four subclasses of the IgG class of antibodies:
IgG1, IgG2, IgG3, and IgG4.
- In healthy individuals, the antibody-producing B-cell can switch from one IgG subclass to another. Patients with IgG subclass deficiencies are born with defective B-cells that are do not mature properly, and they are unable to produce different IgG subclasses. This causes an imbalance of the IgG subclasses, with one or more subclasses being deficient. The overall level of IgG may be normal, but individual subclass levels may be higher or lower than normal.
- Symptoms: Many patients experience no symptoms, while others may suffer from recurrent ear infections, sinusitis (sinus infections), bronchitis, and pneumonia. In rare cases, patients have experienced recurrent episodes of meningitis (infection of the membranes that cover the spinal cord and brain) or bacterial infections of the bloodstream.
Lung function impairment and bronchiectasis (widening and scaring of airways) have also been reported in some patients. Some patients develop autoimmunity. When this occurs, cells in the immune system mistake the body's own tissues for an invading substance.
- Diagnosis: The standard diagnostic test for IgG subclass deficiency is an enzyme-linked immunosorbent assay (ELISA) or a radial immunodiffusion test. These tests measure the level of IgG subclasses in the blood. In healthy individuals, 60-70% of IgG antibodies in the bloodstream are IgG1, 20-30% are IgG2, five to eight percent are IgG3, and one to three percent are IgG4. Test results may vary from one laboratory to another. A healthcare provider should also evaluate the patient's response to vaccines. Patients who have IgG2 subclass deficiency often have poor responses to the Pneumococcal vaccine.
- Treatment: Many patients outgrow their deficiency once they reach adulthood. For those patients who experience persistent deficiencies, antibiotics, intravenous immune globulin (IVIG) therapy, and immunizations may help prevent serious infections and the development of impaired lung function, hearing loss, or other injuries caused by infections. IVIG is made of antibodies extracted from pooled blood donations from hundreds to thousands of donors. IVIG has been shown in some studies to reduce the number of infections and courses of antibiotics in patients who have substantial IgG subclass deficiencies. Doses range from 200 to 400 milligrams/kilogram, given once every three or four weeks.
- Selective IgA deficiency:
- Overview: Selective immunoglobulin A (IgA) deficiency is a primary immune deficiency that occurs when individuals are unable to produce antibodies called immunoglobulin A.
- The B-cells of selective IgA patients are unable to switch from making immunoglobulin M (IgM) to IgA. Healthy individuals express IgM on their B-cells. Once the B-cells come into contact with a foreign substance in the body, they become plasma cells and are capable of producing other antibodies, including IgA.
- The amount of IgA produced is either significantly reduced or absent. Healthy adults have serum IgA levels that range from 90-450mg/dl, while IgA deficient patients have serum levels of 7mg/dl or less.
- The disorder is considered selective because all other antibodies (IgD, IgE, IgG, and IgM) are present at normal or increased levels. Other cells of the immune system, including the T-cells and phagocytic cells, are also produced at normal or increased levels. The T-cells and phagocytic cells are responsible for engulfing (destroying) the foreign substances that are bound to the antibodies.
- Selective IgA deficiency appears to be an inherited disease that is passed down from parents to children. However, the exact genes involved remain unknown.
- Symptoms: Most patients who have selective IgA deficiency experience no symptoms. Because the IgA antibodies protect body surfaces that are frequently exposed to foreign substances from outside of the body (like the nose, throat, lungs, and intestines), these patients may suffer from recurrent infections of these body parts. Ear infections, sinus infections, and pneumonia are the most common infections that occur in symptomatic patients. However, most infections are generally mild.
- Allergies, which range from mild to severe, are also common among patients.
- Diagnosis: A diagnosis of selective IgA deficiency can be made after low or absent levels of IgA are observed in a patient. Healthy adults typically have IgA levels of 100-400 milligrams/deciliter in the blood. The IgA will either be absent or below 7 milligrams/deciliter in patients who have selective IgA deficiency. Immunoglobulin G (IgG) and immunoglobulin M (IgM) will be present in normal levels.
- Treatment: There is currently no cure for selective IgA deficiency. While many patients do not require any medical treatment, some may need antibiotics to treat infections commonly associated with the disorder. Commonly prescribed antibiotics for ear infections include amoxicillin (Trimox® or Biomox®) and Cefuroxime (Ceftin®, Kefurox®, or Zinacef®). Commonly prescribed antibiotics for sinus infections include amoxicillin (Amoxil®, Polymox®, or Trimox®) and trimethoprim/sulfamethoxazole, also called TMP/SMX (Bactrim®, Cotrim®, or Septra). Commonly prescribed antibiotics for pneumonia include azithromycin (Zithromax®), clarithromycin (Biaxin®), erythromycin (Erythrocin® or Ery-Tab®), and amoxicillin and clavulanate (Augmentin®).
- Intravenous immunoglobulin (IVIG) therapy, which is often used to treat other primary immunodeficiencies, should not be used to treat selective IgA deficiency because some patients may develop antibodies to IgA. Once antibodies are created, severe reactions, including anaphylaxis (life-threatening allergic reaction), may occur if the patient receives IVIG.
- Selective IgM deficiency (SIgMD):
- Overview: Selective Immunoglobulin M deficiency (SIgMD) is an immune disorder that occurs when patients have low levels of immunoglobulin M (IgM). Healthy individuals typically have 45-250 milligrams/deciliter of IgM in their blood. Patients with SIgMD typically have concentrations of IgM patients that are lower than 40 milligrams/deciliter.
- Some patients may be born with SIgMD, while others may develop the disorder as a result of another medical condition, such as cancer, an autoimmune disease, or a gastrointestinal problem. Patients who are receiving immunosupressants may also develop SIgMD.
- Some patients may experience no symptoms, while others may have serious infections. Infants and small children are more likely to develop severe infections that may be life threatening because their immune systems are not fully developed. In older children and adults, SIgMD is usually discovered during the investigation of other conditions, such as autoimmune disease or cancer.
- SIgMD is a rare disorder. Researchers estimate that less than 0.03% of the general population and about 1% of hospitalized patients have the disorder.
- Symptoms: Patients may be asymptomatic, while others may experience prolonged or life-threatening infections, especially during infancy. Recurrent infections, including, sinusitis and pneumonia, are caused by bacteria. Patients may also experience atopic or chronic dermatitis, allergic rhinitis (hay fever), wheezing, and/or diarrhea.
- Diagnosis: A nephelometry blood test may be performed to diagnose SIgMD. The disorder is diagnosed after significantly decreased IgM are observed in the patient's blood. During the procedure, a sample of blood is taken from the patient. Anti-immunoglobulins are added to the blood sample. A medical instrument then measures the movement of particles in a substance that is caused by the interaction between immunoglobulins and anti-immunoglobulins. The test quickly and accurately measures the amount of IgM in the patient's blood.
- Treatment: There is currently no cure for SIgMD that is inherited. SIgMD that is caused by another medical condition may resolve once the underlying condition is treated. Treatment focuses on resolving infections associated with the disorder. Commonly prescribed antibiotics include amoxicillin (Trimox® or Biomox®), cefuroxime (Ceftin®, Kefurox®, or Zinacef®), amoxicillin (Amoxil®, Polymox®, or Trimox®), trimethoprim/sulfamethoxazole, also called TMP/SMX (Bactrim®, Cotrim®, or Septra), azithromycin (Zithromax®), clarithromycin (Biaxin®), erythromycin (Erythrocin® or Ery-Tab®), and amoxicillin and clavulanate (Augmentin®).
- Transient hypogammaglobulinemia of infancy (THI):
- Overview: Transient hypogammaglobulinemia of infancy (THI) is a temporary immunodeficiency that occurs when patients have low levels of immunoglobulin G (IgG), the most common antibody in the bloodstream. Immunoglobulins are antibodies that help the body fight against disease and infection. Additional types of antibodies, including immunoglobulin A (IgA), may also be low in children with THI.
- In healthy babies, antibody levels in the blood reach a natural low point when they are between three and four months of age. This happens because babies are no longer receiving IgG from their mothers, and they are unable to produce their own yet. Once healthy babies reach six months of age, their antibodies are produced at a normal rate.
- In children who have THI, the levels of IgG and IgA levels remain low after six months of age because not enough immunoglobulin is produced. Babies who are born prematurely are at an even greater risk of developing THI because they had less time to build up antibody supplies before birth. There appears to be no correlation between breastfeeding and THI.
- Researchers estimate that THI affects about 1 out of 10,000 children. However, this number may be higher because some children experience few or no symptoms, and they might not be diagnosed.
Symptoms of THI vary. Some children may experience few or no symptoms while others may experience recurrent infections. In general, children who have THI suffer from milder infections that are caused by more typical bacteria and viruses than children with more severe immune deficiencies. Common symptoms of THI include recurrent ear infections or non-infectious inflammation of the middle ear, recurrent bronchitis, frequent sinusitis (infection or inflammation of the sinuses), bacterial infection (like pneumonia), infections of the skin, and meningitis (infection of the membranes that cover the spinal cord and brain).
- Diagnosis: THI is usually suspected if a child experiences recurrent infections past the age of six months. A blood test can indicate low levels of antibodies in the bloodstream. However, this is a nonspecific diagnostic test because many other immune disorders cause low levels of antibodies. A definitive diagnosis can only be made once the condition has resolved on its own.
- Treatment: THI will resolve on its own, without treatment. However, THI patients have an increased risk of developing infections and may need antibiotic treatment. Intravenous immune globulin (IVIG) therapy is controversial, but may be beneficial in some patients. IVIG is made of antibodies extracted from pooled blood donations from hundreds to thousands of donors. A qualified healthcare provider should closely monitor the patient's antibody levels several times a year to check for improvement, and to ensure that a more serious immunodeficiency disorder is not present.
- Most children require antibiotics like amoxacillin (Amoxil®, Amoxil® Pediatric Drops, or Trimox® Pediatric Drops) or cefuroxime (Ceftin® or Zinacef®) to treat bacterial infections associated with THI.
- There is still debate over whether IVIG therapy is helpful for THI patients because it delays the child's normal antibody formation. There is also the risk of allergic reaction to the therapy. Therefore, IVIG may be more beneficial in patients with severe infections who are not responding to antibiotics. Patients should consult their qualified healthcare providers to evaluate the risks and benefits.
- Children with THI are given routine immunizations. In general, most children with THI respond normally to vaccines.
- X-linked agammaglobulinemia:
- Overview: X-linked agammaglobulinemia is an inherited immunodeficiency that occurs when patients have low levels of all types of immunoglobulin (IgA, IgD, IgE, IgG and IgM) in the blood. Immunoglobulins are antibodies that help the body fight against disease and infection.
- The disease is inherited as an X-linked recessive trait. This means the mutated gene that causes the disorder is located on the X chromosome. Since males only have one X chromosome, the disorder affects males almost exclusively. If a male inherits the mutated gene, he will develop the disease 100% of the time. Females, on the other hand, have two X chromosomes. Females need to inherit two mutated X chromosomes in order to develop the disease. If a female inherits the mutated gene, chances are the other gene will be healthy because the disease is not common. However, if the female inherits one mutated gene, she is a carrier for the disease and there is a 50% chance that she will pass the gene to each of her children.
- The mutated gene prevents the B-cells from developing into mature cells. Mature B-cells play an important role in the immune response because they produce antibodies. Consequently, patients with agammaglobulinemia have decreased levels of all types of antibodies in their blood.
- Symptoms: Symptoms of X-linked agammaglobulinemia may include frequent pus-producing infections, ear infections, lung infections, sinus infections, pneumonia, missing tonsils, missing adenoids, and delayed growth.
- Diagnosis: A diagnosis of X-linked agammaglobulinemia can be made after low or absent levels of all antibodies are observed in the patient's blood. Patients typically have lower than 200mg/dL of IgG in the blood. IgA and IgM are almost undetectable.
- Treatment: There is currently no cure for agammaglobulinemia. Treatment focuses on relieving symptoms and boosting the body's immune system to prevent future infections. Commonly prescribed antibiotics include amoxicillin (Trimox® or Biomox®), cefuroxime (Ceftin®, Kefurox®, or Zinacef®), amoxicillin (Amoxil®, Polymox®, or Trimox®), trimethoprim/sulfamethoxazole, also called TMP/SMX (Bactrim®, Cotrim®, or Septra), azithromycin (Zithromax®), clarithromycin (Biaxin®), erythromycin (Erythrocin® or Ery-Tab®), and amoxicillin and clavulanate (Augmentin®).
- Intravenous immune globulin (IVIG) is often used to boost the body's immune system. IVIG is made of antibodies extracted from pooled blood donations from hundreds to thousands of donors. The immunoglobulin is typically injected into the patient's vein for about two to four hours a day for two to seven days. The patient usually receives another single dose every 10-21 days or every three to four weeks, depending on the severity of the condition. Treatment is typically administered every two to three weeks for life.
Copyright © 2011 Natural Standard (www.naturalstandard.com)
The information in this monograph is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions.